Paliperidone ER: a review of the clinical trial data

Paliperidone extended-release tablet (paliperidone ER; INVEGA(™)) is an oral antipsychotic for the treatment of schizophrenia. The recommended dose range is 3–12 mg per day. Paliperidone ER utilizes the OROS(®) delivery system, which allows for once-daily dosing. Its pharmacokinetic profile results...

Descripción completa

Detalles Bibliográficos
Autores principales: Janicak, Philip G, Winans, Elizabeth A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656329/
https://www.ncbi.nlm.nih.gov/pubmed/19300622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656329/
https://www.ncbi.nlm.nih.gov/pubmed/19300622

Ejemplares similares